Development of a pharmacy-based comorbidity index for patients with cancer

scientific article

Development of a pharmacy-based comorbidity index for patients with cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/MLR.0000000000000149
P698PubMed publication ID24926705

P50authorBee Teng LimQ92764977
Diana SarfatiQ47236709
Jason GurneyQ88286347
James StanleyQ88429702
P2093author name stringClaire McSherry
P433issue7
P921main subjectcomorbidityQ1414874
pharmacyQ614304
P304page(s)586-593
P577publication date2014-07-01
P1433published inMedical CareQ15762119
P1476titleDevelopment of a pharmacy-based comorbidity index for patients with cancer
P478volume52

Reverse relations

cites work (P2860)
Q48123202Adapting the Elixhauser comorbidity index for cancer patients.
Q47999230Development and validation of a Medicines Comorbidity Index for older people.
Q47917865Evaluation of the National Minimum Data Set for Neurological Conditions in Older Adults
Q37316811Medication use trajectories of postmenopausal breast cancer survivors and matched cancer-free controls
Q36104585Modification of claims-based measures improves identification of comorbidities in non-elderly women undergoing mastectomy for breast cancer: a retrospective cohort study.
Q36190140Risk of Cancer in Patients with Insomnia, Parasomnia, and Obstructive Sleep Apnea: A Nationwide Nested Case-Control Study
Q89679100The burden of chronic diseases among Australian cancer patients: Evidence from a longitudinal exploration, 2007-2017
Q26764935The impact of comorbidity on cancer and its treatment

Search more.